Navigation Links
Helix BioPharma Corp. Announces Fiscal 2008 Results
Date:10/28/2008

Euro dollar appreciated against all currencies. The net assets in Europe consist mainly of cash and cash equivalents, denominated in Euro dollars and are used to fund clinical trials of the Topical Interferon Alpha-2b in Europe.

Impairment of intangible assets totaled $nil in fiscal 2008 and $1,332,000 in fiscal 2007. The Company believed future cash flows may not exceed the carrying value of its biochip technology and in fiscal 2007 recorded an impairment of its biochip technology.

Income tax expenses totaled $153,000 in fiscal 2008 and $105,000 in fiscal 2007. Income taxes are attributable to the Company's operations in Europe where royalty revenue remained flat on a year over year basis.

Liquidity and Capital Resources

Since inception, the Company has financed its operations from public and private sales of equity, the exercise of warrants and stock options, and, to a lesser extent, on interest income from funds available for investment, government grants, investment tax credits, and revenues from distribution, licensing and contract services. Since the Company does not have net earnings from its operations, the Company's long-term liquidity depends on its ability to access the capital markets, which depends substantially on the success of the Company's ongoing research and development programs.

At July 31, 2008, 2007 and 2006, the Company had cash and cash equivalents totaling $19,057,000, $11,379,000 and $4,392,000 respectively. The increase in cash and cash equivalents is the result of several rounds of private placements. In fiscal 2007, the Company completed a private placement issuing 3,650,000 units at $1.93 per unit, for gross proceeds of $7,044,500. Each unit consisted of one common share and one common share purchase warrant. The common share purchase warrants expired, unexercised on March 31, 2008. In fiscal 2008, the Company completed another private placement issuing 10,040,000 common shares at $1.68 per common sha
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Helix Biopharma Closes $11.4 Million Private Placement
2. Helix BioPharma Announces $11.4 Million Private Placement
3. Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canadas Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada
4. Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences
5. Helix BioPharma product development update, quarterly highlights and financial results for fiscal Q3 2008
6. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
7. Helix BioPharma reports Q2 2008 highlights, financial results
8. Helix BioPharma shareholders vote in favour of management
9. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
10. Helix BioPharma closes $16.9 million private placement of common shares
11. Helix BioPharma announces Q1 2008 financial results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... (PRWEB) August 27, 2014 The Global ... in-depth study on the current state of the Trifluoroacetic ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
(Date:8/27/2014)... Aug. 27, 2014 Research and ... "Global Lactic Acid  (Biodegradable Polymer, Food & Beverage, ... Forecasts to 2019" report to their offering. ... acid with an asymmetrical carbon atom. The main ... polymer, food and beverage, personal care product, and ...
(Date:8/27/2014)... MADISON, N.J. , Aug. 27, 2014 /PRNewswire/ ... significant potential to help physicians better identify early-stage ... progression and disability, according to a new study ... from Quest Diagnostics (NYSE: DGX ) ... of the 14-3-3eta protein outperformed conventional antibody-serum testing, ...
(Date:8/27/2014)... YORK , Aug. 27, 2014 Guggenheim ... Guggenheim Partners, today announced the hiring of veteran equity ... senior equity analyst. Mr. Butler will focus on the ... our team a wealth of experience and a broad ... Ferrarie , Senior Managing Director and Head of Equities ...
Breaking Biology Technology:Trifluoroacetic Acid Industry (Asia, Europe, North America, ROW) Analysis Report Now Available at ReportsnReports.com 2Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2
... SAN DIEGO, May 4 Bio-Matrix Scientific Group Inc. ... ) and Entest BioMedical Inc., its wholly owned subsidiary, ... Report to the U.S. Army Medical Research and Materiel ... therapeutic potential of adipose-derived stem cells (ASCs) harvested from ...
... Inc. ("Senesco" or the "Company") (NYSE Amex: SNT ... 31, 2009. Net loss for the three month period ended ... a net loss of $1,482,217, or $0.08 per share, for the ... net loss was primarily the result of a decrease in operating ...
... Inc. (OTC Bulletin Board: PLMO; Frankfort Borse: PLO) has ... of its Pulmo Science Inc. subsidiary and the originator ... at the 5th International Symposium on Peptide Receptors and ... June 26th to 29th. The paper, which is ...
Cached Biology Technology:Bio-Matrix Scientific Group & Entest BioMedical Submit Research Proposal to U.S. Army for Funding Adipose-Derived Stem Cells to Treat Traumatic Brain Injury 2Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 2Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 3Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 4Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 5Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 6Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results 7Pulmo BioTech Inc. Announces Paper to be Presented at Symposium 2Pulmo BioTech Inc. Announces Paper to be Presented at Symposium 3
(Date:8/27/2014)... getting effective doses of the HIV drug maraviroc, a ... studies, completed before the drug was licensed in 2007, ... is key to removing maraviroc from the body. The ... the protein including nearly half of African-Americans ... to those who lack the protein even when given ...
(Date:8/27/2014)... easier when it is related to ability that we ... a new melody more easily than learning how to ... Center for the Neural Basis of Cognition (CNBC)a joint ... Universityhave discovered a fundamental constraint in the brain that ... story in the Aug. 28, 2014, issue of ...
(Date:8/27/2014)... An invasive grass species frequently found in forests ... then feed on American toads, a new University of ... accidentally introduced to the U.S. in the early 1900s, ... has spread to more than a dozen states in ... along roads and in forests, it can survive in ...
Breaking Biology News(10 mins):Dosage of HIV drug may be ineffective for half of African-Americans 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 3More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3
... May 2, 2008 Wiley-Blackwell, the scientific, technical, medical, ... Sons, Inc. today announced the launch of Journal ... the Chartered Institution of Water and Environmental Management ... exploring the interactions between the diverse fields that ...
... new mechanism of infection for the most fatal bee ... which can kill entire colonies of bees. Every year, ... beekeepers all over the world. The only control measure ... of infection (pathogenic mechanism) was originally thought to be ...
... Moms they take fathering to a whole new level: ... to play the dominant parenting role, male pregnancy is a ... pipefish, seahorses and sea dragons. Texas A&M University evolutionary biology ... the effects of male pregnancy on sex roles and sexual ...
Cached Biology News:Wiley-Blackwell to launch Journal of Flood Risk Management 2Bees disease -- 1 step closer to finding a cure 2Male seahorses are nature's Mr. Mom, Texas A&M researchers say 2Male seahorses are nature's Mr. Mom, Texas A&M researchers say 3Male seahorses are nature's Mr. Mom, Texas A&M researchers say 4
... Uncover the biological data hidden in your samples ... manufacturing allows you to create your own microarray ... at your own pace and receive delivery of ... eArray is a secure, online array creation application ...
... The high-performance triple quadrupole 1200L ... in today's cost-conscious environment - incorporating ... solutions for all liquid chromatography analytical ... (API) interface and the Transmission Quadrupole ...
C1-inhibitor (C1-INH)...
... ATP-Free using Mo Bio luciferase assay. Mo Bio ... that will allow you to certify your products ... enable you to deliver them to your customers ... detection limit is 3.5 x 10-12 /l, which ...
Biology Products: